CNSP
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
May 17, 6:59 PM EST
STRO
Price
$4.01
Change
-$0.14 (-3.37%)
Updated
May 17, 6:59 PM EST
82 days until earnings call
Ad is loading...

CNSP vs STRO

Header iconCNSP vs STRO Comparison
Open Charts CNSP vs STROBanner chart's image
CNS Pharmaceuticals
Price$0.22
Change-$0.00 (-0.00%)
Volume$89.57K
CapitalizationN/A
Sutro Biopharma
Price$4.01
Change-$0.14 (-3.37%)
Volume$276.12K
CapitalizationN/A
View a ticker or compare two or three
CNSP vs STRO Comparison Chart

Loading...

CNSPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
STRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CNSP vs. STRO commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Hold and STRO is a StrongBuy.

COMPARISON
Comparison
May 18, 2024
Stock price -- (CNSP: $0.22 vs. STRO: $4.01)
Brand notoriety: CNSP and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 87% vs. STRO: 38%
Market capitalization -- CNSP: $2.32M vs. STRO: $328M
CNSP [@Biotechnology] is valued at $2.32M. STRO’s [@Biotechnology] market capitalization is $328M. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 0 green FA rating(s).

  • CNSP’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNSP and STRO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 5 bullish TA indicator(s).

  • CNSP’s TA Score: 4 bullish, 4 bearish.
  • STRO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STRO is a better buy in the short-term than CNSP.

Price Growth

CNSP (@Biotechnology) experienced а +10.94% price change this week, while STRO (@Biotechnology) price change was -3.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

CNSP is expected to report earnings on Mar 16, 2023.

STRO is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CNSP with price predictions.
OPEN
A.I.dvisor published
a Summary for STRO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
STRO($328M) has a higher market cap than CNSP($2.32M). STRO YTD gains are higher at: -6.527 vs. CNSP (-82.913).
CNSPSTROCNSP / STRO
Capitalization2.32M328M1%
EBITDAN/AN/A-
Gain YTD-82.913-6.5271,270%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CNSPSTRO
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CNSPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
STRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNTC9.490.02
+0.21%
Benitec Biopharma
PAC193.63-0.12
-0.06%
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares)
TAC7.22-0.09
-1.23%
TransAlta Corp
TIVC0.47-0.01
-2.89%
Tivic Health Systems
ESPR2.36-0.23
-8.88%
Esperion Therapeutics

CNSP and

Correlation & Price change

A.I.dvisor tells us that CNSP and NRIX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNSP and NRIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-3.51%
NRIX - CNSP
26%
Poorly correlated
+7.73%
STRO - CNSP
26%
Poorly correlated
-3.37%
REVB - CNSP
26%
Poorly correlated
+8.60%
CALC - CNSP
25%
Poorly correlated
+0.37%
ALGS - CNSP
25%
Poorly correlated
+5.11%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with BCAB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-3.37%
BCAB - STRO
44%
Loosely correlated
-8.71%
ALGS - STRO
44%
Loosely correlated
+5.11%
STOK - STRO
42%
Loosely correlated
-0.93%
NUVB - STRO
38%
Loosely correlated
-2.64%
ALLO - STRO
38%
Loosely correlated
-7.97%
More